| Literature DB >> 31173475 |
Kang Xie1, Yi-Jia Lu1, Kun Yang1, Shi-Mei Huo1, Xiao-Yue Hong1.
Abstract
Wolbachia and Spiroplasma are intracellular bacteria that are of great interest to entomologists, because of their ability to alter insect host biology in multiple ways. In the spider mite Tetranychus truncatus, co-infection of Wolbachia and Spiroplasma can induce cytoplasmic incompatibility (CI) and fitness costs; however, little is known about the effect of co-infection at the genetic level and the molecular mechanisms underlying CI. In this study, we explored the influence of the two symbionts on male mite host fitness and used RNA sequencing to generate the transcriptomes of T. truncatus with four different types of infection. In total, we found symbiont-infected lines had a higher hatch proportion than the uninfected line, and the development time of the uninfected line was longer than that of the other lines. Co-infection changed the expression of many genes related to digestion detoxification, reproduction, immunity and oxidation reduction. Our results indicate that co-infection of Wolbachia and Spiroplasma confers multiple effects on their hosts, and helps illuminate the complex interactions between endosymbionts and arthropods.Entities:
Keywords: Spiroplasma; Tetranychus truncatus; Wolbachia; co-infection; development time; transcriptome
Year: 2019 PMID: 31173475 PMCID: PMC7497181 DOI: 10.1111/1744-7917.12696
Source DB: PubMed Journal: Insect Sci ISSN: 1672-9609 Impact factor: 3.262
Figure 1Hatch proportion of different male Tetranychus truncatus lines. Iws, doubly infected line; Iw, singly Wolbachia‐infected line; Is, singly Spiroplasma‐infected line; U, uninfected line. Results are mean ± SEM (Tukey Honestly Significant Difference test, P < 0.05).
Figure 2Development times of different male Tetranychus truncatus lines. Iws, doubly infected line; Iw, singly Wolbachia‐infected line; Is, singly Spiroplasma‐infected line; U, uninfected line. The differences of development time were analyzed using the Kruskal–Wallis test with Bonferroni correction (* P < 0.05; *** P < 0.001).
Summary of sequencing results
| Sample name | ||||
|---|---|---|---|---|
| Iws (%) | Iw (%) | Is (%) | U (%) | |
| Raw reads | 53428652 | 52031996 | 54450407 | 50926184 |
| Clean reads | 52453167 | 51200051 | 53717187 | 49889247 |
| Total mapped | 46903947 (89.42) | 45414792 (88.70) | 48057361 (89.46) | 44151453 (88.50) |
| Total unigenes | 58015 | |||
| Median length | 2408 | |||
| N50 | 5456 | |||
| N90 | 1731 | |||
| Larger than 2 kb | 32384 | |||
Iws, doubly infected line; Iw, singly Wolbachia‐infected line; Is, singly Spiroplasma‐infected line; U, uninfected line.
Figure 3Number of unigenes annotated from each database.
Figure 4Species classification chart based on unigenes annotated from the Nr database; 84.3% of unigenes were assigned to Tetranychus truncatus.
Figure 5Volcano plot of differentially expressed genes in doubly infected (Iws) and uninfected (U) lines.
Figure 6Volcano plot of differentially expressed genes in doubly infected (Iws) and singly Spiroplasma‐infected (Is) lines.
Figure 7Volcano plot of differentially expressed genes in doubly infected (Iws) and singly Wolbachia‐infected (Iw) lines.
Figure 8Gene Ontology enrichment analysis of differentially expressed genes between doubly infected (Iws) and uninfected (U) lines.
Figure 9Gene Ontology enrichment analysis of differentially expressed genes between doubly infected (Iws) and singly Wolbachia‐infected (Iw) lines.
Figure 10Gene Ontology enrichment analysis of differentially expressed genes between doubly infected (Iws) and singly Spiroplasma‐infected (Is) lines.
Figure 11The 20 most enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways based on differentially expressed genes between doubly infected (Iws) and uninfected (U) lines. The x‐axis shows the rich factor. The y‐axis shows the pathway name. The point size represents the number of genes enriched in a particular pathway. Degree of enrichment is more significant for larger rich factor values and smaller q values.
Figure 12The 20 most enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways based on differentially expressed genes between doubly infected (Iws) and singly Spiroplasma‐infected (Is) lines. The x‐axis shows the rich factor. The y‐axis shows the pathway name. The point size represents the number of genes enriched in a particular pathway. Degree of enrichment is more significant for larger rich factor values and smaller q values.
Figure 13The 20 most enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways based on differentially expressed genes between doubly infected (Iws) and singly Wolbachia‐infected (Iw) lines. The x‐axis shows the rich factor. The y‐axis shows the pathway name. The point size represents the number of genes enriched in a particular pathway. Degree of enrichment is more significant for larger rich factor values and smaller q values.
Subset of identified differentially expressed genes
| log2 (Fold Change) | |||||
|---|---|---|---|---|---|
| Gene category | Gene ID | Description | Iws vs U | Iws vs Is | Iws vs Iw |
| Digestion or detoxification |
| Acetylcholinesterase‐like precursor | −3.9453 | −3.8502 | −3.5378 |
|
| Acetylcholinesterase‐like precursor | −9.4156 | – | – | |
|
| Acetylcholinesterase‐1 | – | −6.594 | – | |
|
| Cholinesterase | 11.407 | 14.79 | – | |
|
| Cholinesterase | 11.212 | 11.31 | – | |
|
| Cholinesterase | 7.1257 | 7.5336 | – | |
|
| Cholinesterase | 8.309 | 6.5407 | – | |
|
| Cholinesterase | 7.3991 | 7.4976 | – | |
|
| Cholinesterase | 7.1807 | 7.2838 | – | |
|
| Cholinesterase | 16.297 | 16.394 | – | |
|
| Multidrug resistance‐associated protein 1 | 22.075 | 22.171 | – | |
|
| Multidrug resistance‐associated protein 1 | −6.7113 | – | −6.0865 | |
|
| Multidrug resistance‐associated protein 4 | 8.8705 | – | – | |
|
| Multidrug resistance‐associated protein 1 | – | −3.8554 | – | |
|
| Multidrug resistance‐associated protein 1 | – | −6.3218 | – | |
|
| Multidrug resistance‐associated protein 1 | – | 4.4568 | – | |
|
| Multidrug resistance‐associated protein 1 | – | 3.3699 | 2.3407 | |
|
| Multidrug resistance‐associated protein 4 | – | −1.6863 | – | |
|
| Multidrug resistance‐associated protein 1 | – | – | −6.7381 | |
|
| Multidrug resistance‐associated protein 4 | – | – | 4.4642 | |
|
| Multidrug resistance‐associated protein 4 | – | – | 1.9779 | |
|
| Canalicular multispecific organic anion transporter 1 | – | – | −4.7031 | |
|
| Canalicular multispecific organic anion transporter 2 | – | – | −1.2515 | |
|
| UDP‐glucosyltransferase YdhE | −5.8003 | – | – | |
|
| UDP‐glucosyltransferase YjiC | 8.2717 | 5.8864 | – | |
|
| UDP‐glucosyltransferase YjiC | −6.7652 | – | – | |
|
| UDP‐glucosyltransferase YjiC | 6.852 | – | – | |
|
| UDP‐glucosyltransferase YjiC | – | 1.6587 | – | |
|
| UDP‐glucosyltransferase YjiC | – | −6.3608 | – | |
|
| UDP‐glucose:glycoprotein glucosyltransferase 1 | – | – | 10.187 | |
|
| UDP‐glucosyltransferase YjiC | – | – | −1.7827 | |
|
| UDP‐glycosyltransferases | – | – | −2.5221 | |
|
| UDP‐glucosyltransferase YojK | – | – | −4.7457 | |
| Lipocalins |
| Apolipoprotein D | −3.7197 | −4.2719 | – |
|
| Apolipoprotein D | −1.4002 | – | – | |
|
| Apolipoprotein D | −7.2849 | – | – | |
|
| Apolipoprotein D | – | −9.2612 | −9.1475 | |
|
| Apolipoprotein D | – | – | 5.8735 | |
|
| Apolipoprotein D | – | – | −6.3934 | |
| Reproduction |
| Histone variant H2A.Z | −6.1468 | – | – |
|
| Histone deacetylase complex subunit SAP130 | 1.1359 | – | – | |
|
| Histone H3.3 | −7.39 | – | – | |
|
| Histone‐lysine N‐methyltransferase SETD1B | – | −7.3224 | – | |
|
| Histone‐lysine N‐methyltransferase SETMAR | – | −3.06 | −3.3232 | |
|
| Histone‐lysine N‐methyltransferase SETD1B | – | – | 2.5072 | |
|
| Integrin beta pat‐3 | – | – | −1.1589 | |
|
| Integrin beta pat‐3 | – | – | 1.0747 | |
|
| Cyclin‐G‐associated kinase | 2.1506 | – | – | |
|
| DNA topoisomerase 2‐alpha | 14.238 | 14.334 | 14.391 | |
|
| DNA topoisomerase 2‐alpha | 13.197 | 13.294 | 13.351 | |
|
| DNA topoisomerase 2‐alpha | 12.187 | – | – | |
|
| DNA topoisomerase 2‐alpha | – | −1.9319 | −2.0822 | |
|
| DNA topoisomerase 2‐alpha | – | −1.7772 | −2.1526 | |
|
| Ecdysone‐inducible protein E75 | – | – | 1.8406 | |
|
| Ecdysone‐induced protein 78C | – | 1.1858 | 1.2414 | |
| Immunity |
| Serine/threonine‐protein kinase pelle | 9.4517 | 9.5598 | – |
|
| Nuclear factor‐kappa‐B p100 subunit | 11.588 | 11.688 | – | |
|
| Nuclear factor‐kappa‐B p105 subunit | 7.7836 | – | – | |
|
| Nuclear factor‐kappa‐B p100 subunit | 11.605 | 11.701 | – | |
|
| Nuclear factor‐kappa‐B p105 subunit | −8.0926 | −8.0389 | −8.5413 | |
|
| JAK/STAT pathway ortholog of Dm stat92E | 4.5353 | – | – | |
|
| JAK/STAT pathway ortholog of Dm stat92E | 4.8424 | – | – | |
|
| JAK/STAT pathway ortholog of Dm stat92E | 5.5734 | – | – | |
|
| Toll‐like receptor Tollo | – | 1.2988 | – | |
| Oxidation reduction process |
| Dual oxidase 2 | – | – | 6.662 |
|
| Dual oxidase maturation factor 2 | – | – | 9.3804 | |
|
| Dual oxidase maturation factor 2 | – | – | 7.7968 | |
|
| Peroxidase | −5.8252 | – | – | |
|
| Peroxidase | – | – | 2.0365 | |
|
| Short‐chain dehydrogenase | – | −9.4161 | −9.4985 | |
|
| Short‐chain dehydrogenase | – | −8.7428 | −8.4418 | |
|
| Ferritin, heavy subunit | −7.1255 | – | – | |
|
| Ferritin, middle subunit | −7.3421 | – | – | |
| Structural constituent of cuticle |
| Adult‐specific rigid cuticular protein 15.7 | −2.7772 | −2.5967 | −2.3873 |
|
| Adult‐specific rigid cuticular protein 15.7 | −2.1123 | −2.326 | −2.1123 | |
Iws, doubly infected line; Iw, singly Wolbachia‐infected line; Is, singly Spiroplasma‐infected line; U, uninfected line.
Figure 14Expression patterns of differentially expressed genes in different symbiont‐infected lines. (A) Doubly infected (Iws) compared with uninfected (U) lines. (B) Iws compared with singly Spiroplasma‐infected (Is) lines. (C) Iws compared with singly Wolbachia‐infected (Iw) lines. Relative expression was calculated using the 2−ΔΔCt method. Data are presented as mean ± SEM.